Home
overview
Latest News: The conference will also include a unique insight into the recent high-profile counterfeit drugs case in the UK, which was successfully resolved with the help of Pfizer and the MHRA. Also, we will get an insight into packaging small orders efficiently from Eli Lilly.

Industry dangers including the constant threat of counterfeit packaging and labelling, and the waves of new business regulations that are changing across Europe are having huge implications to pharmaceutical packaging and labelling strategies. Ensuring drug safety across the supply chain, understanding and complying with the latest regulatory standards for drug labelling, and keeping current on the newest and most pioneering packaging methods technology are just a taste of the issues that will be tackled at SMi’s 4th Pharmaceutical Packaging and Labelling Conference.

SMi’s 4th Pharmaceutical Packaging and Labelling Innovations Conference is the place to be if you want to keep up-to-date with the latest industry developments and network with an international audience of fellow pharmaceutical packaging and labelling professionals.

6 Key Benefits of Attending

1. DISCOVER new practical approaches to anti-counterfeiting methods and authentication techniques
2. UNDERSTAND current and future regulatory issues within the pharmaceutical packaging and labelling industry (MHRA)
3. LEARN how to tackle the new ICH Q9 Quality Risk Management Guideline
4. DEVELOP the best cost-effective methods of the production process
5. INVESTIGATE different strategies of improving supply chain security
6. NETWORK with an array of experts in the packaging and labelling industry

Hear contributions from leading industry experts, including:

  • Dr Anders Lofgren, Executive Product Design, AstraZeneca
  • Jonathon Rucker, Director of Manufacturing, Eli Lilly
  • Ingo Kaemmer, Head of Purchasing and Packaging Materials, Sandoz
  • Max Vetter, Manager, ICC Counterfeiting Intelligence Bureau
  • Ralph Dillon, Managing Director, Chicago Office, Compliance Surety Associates
  • Danny Lee-Frost, Head, Enforcement, Medicines Healthcare products Regulatory Agency (MHRA)
  • Dr John Gill, Senior Scientist, Royal National Institute for the Blind (RNIB)
  • Stephen Wilkins, Chief Executive, Child Safety Packaging Group
  • Dr Andreas Franken, Clinical Research / eSubmission, BAH
  • Dr Klaus Menges, Head, Institute of Medicine Product and Strategy, Bfarm
  • Marc Sluijs, EMEA Business Development Director Life Sciences, Oracle
  • Professor David Cousins, Head of Safe Medication Practice, National Patient Safety Agency

This event is aimed at those with the following job titles:

• Director of  Packaging
• Director of Labelling
• Director of Quality Control
• Head of Manufacturing
• Director of Supply Chain
• Head of Logistics
• Head of Security
• Director of Operations
• Quality Assurance Director
• Director of Packaging and Labelling Design
• Director of  Regulations
• Head of Compliance

Previous attendees were from the following companies:

  • Wyeth
  • GlaxoSmithKline
  • Teva
  • Sanofi-Aventis
  • Sandoz
  • Pfizer
  • Novartis
  • AstraZeneca
  • Cardinal Health
  • Alpharma
  • Allergan
  • MHRA
  • Penn Pharmaceuticals
  • BAH
  • Bfarm
  • Ipsen
  • Hewlett Packard
  • Domino UK
  • Brecon Pharmaceuticals
  • Schreiner Group
  • Chrion Corp.
  • GS1 UK
  • Pharmion
  • RNIB
  • Zebra Technologies
  • ABPI
  • Americansource Bergen
  • Alpvision
  • Handicap Zero
  • Jerini AG

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Laura Cohen

Laura Cohen, Regulatory and International Packaging Project Manager, AstraZeneca

9:10 INNOVATIVE STRATEGIES TO FACILITATE THE PACKAGING SUPPLYCHAIN IN THE GENERIC PHARMACEUTICAL INDUSTRY

Ingo Kaemmer

Ingo Kaemmer, Head of Technical Packaging, Sandoz Ag

  • Turning Packaging Strategy into reality – The Enablers
  • Harmonisation & Rationalisation, dealing with Growth by Acquisition, Global Synergies, Legislation, New EU
  • Lean Procurement models based on Automotive thinking that work in the European Market
  • Question and Answer session/discussion
  • 9:50 PATIENT ADHERENCE – WHAT IS THE ROLE OF DRUG PACKAGING?

    Dr Anders Lofgren

    Dr Anders Lofgren, Packaging/Device development, AstraZeneca

  • What is patient non-adherence and why is it happening?
  • How can packaging and related components impact patients, physicians etc?
  • What regulatory aspects exist?
  • What technology is out there, and what do we see coming?
  • 10:30 Morning Coffee

    10:50 SECURE TRACEABILITY - A NEW APPROACH TO PRODUCT PROTECTION

    Jacob Götzsche

    Jacob Götzsche, Managing Director, FractureCode Corporation

    • Adding a unique “fingerprint” to secure products
    • Registration of genuine products as they’re produced
    • Linking technologies to provide comprehensive product security
    • Securing open standard coding systems

    11:30 PATIENT NON-COMPLIANCE LABELLING ISSUES AND SOLUTIONS.

    Dr John Gill OBE

    Dr John Gill OBE, Chief Scientist, Royal National Institute for Blind People

  • The main reasons for non-compliance labelling for the blind
  • Bypassing EU regulations on Braille labelling
  • The need for more compliant labelling rather than Braille?
  • Displaying patient information in different formats
  • 12:10 UNLOCKING VALUE IN YOUR PACKAGING AND LABELLING PROCESSES

    Marc Sluijs

    Marc Sluijs, EMEA Business Development Director, Oracle

    • Detailed insight in global product portfolio
    • Improved efficiency of pack & label management
    • Real-time insight and control over the processes
    • Reduced risk of errors and compliance exposure

    12:50 Networking Lunch

    13:50 LASER SURFACE AUTHENTICATION (LSA) – NATURAL RANDOMNESS AS A ‘FINGERPRINT’ FOR PHARMACEUTICAL AUTHENTICATION

    Mark McGlade

    Mark McGlade, Director, Business Development, INGENIA TECHNOLOGY

  • Case study: technology, known as “Laser Surface Authentication” or LSA™
  • Which reads the surface of the inherent structure of paper, packaging and plastics
  • The laser sensor can be applied to production lines with minimum impact to operations
  • Recording the inherent ‘fingerprint’ of every item on the line and storing in a database
  • 14:30 ELECTRONICALLY SUPPORTED MANAGEMENT FOR PRODUCT INFORMATION - THE PIM SYSTEM

    Dr Andreas Franken

    Dr Andreas Franken, Clinical Research / eSubmission, BAH

  •  How the system will work
  • Current experiences from applicant's and agency's side
  • Challenges for the business process
  • Outline of future developments
  • Possible use in other procedures than the centralised
  • 15:10 PACKAGE LEAFLETS – COMPREHENSION SUPPORTED BY USER TESTING AND PIM?

    Dr Klaus Menges

    Dr Klaus Menges, Head, Institute of Medicine Product and Strategy, Bfarm

  • Two years experience with user testing reports
  • Faults diagnosed by competent authorities
  • Recommendations for reporting consultations with target patient groups
  • Electronic support in creating and assessing product information - PIM
  • Advantages from agency’s point of view
  • 15:50 Afternoon Tea

    16:10 DEVELOPING COST-EFFECTIVE PATIENT-FRIENDLY CHILD RESISTANT PACKAGING

    Stephen Wilkins

    Stephen Wilkins, Secretary General, Child - Safe Packaging Group

  • Why CR packaging has been previously expensive?
  • Review of worldwide CR packaging legislation
  • Simple cost-effective CR solutions
  • Examples from third world manufacturers (South America)
  • Key issues for product usability
  • 16:50 MEDICINES LABELLING AND PACKAGING DESIGN CAN IMPROVE PATIENT SAFETY

    Professor David Cousins

    Professor David Cousins, Head of Safe Medication Practice, National Patient Safety Agency

  • The role of the NPSA is to minimise patient safety incidents (preventable harms)
  • The NPSA collect information about patient safety incidents via the National Reporting and Learning System that enables all NHS organisations in England and Wales to report incidents
  • Reviewing incident information, identifying high risks and issuing advice to the NHS to help eliminate and minimise these risks
  • Better designing of medicines, medical devices, building and systems is a very effective method to improve patient safety
  • Design for Patient Safety Publications to describe design principles, to be incorporated into healthcare products
  • 17:30 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Laura Cohen

    Laura Cohen, Regulatory and International Packaging Project Manager, AstraZeneca

    9:10 OPERATION STORMGRAND, A COUNTERFEIT CASE STUDY

    Danny Lee-Frost

    Danny Lee-Frost, Head of Enforcement, Medicines & Healthcare products Regulatory Agency (MHRA)

  • MHRA Anti-Counterfeiting Strategy
  • Stormgrand Investigation
  • Court Case
  • Future cases
  • 9:50 BLISTER PRINTING ENABLES ‘LATE STAGE CUSTOMISATION’ AND DELIVERS NEW CAPABILITIES IN THE FIGHT AGAINST DRUG COUNTERFEITING

    Jon Harris

    Jon Harris, Sales Manager, G-MAT Ltd

  • Digital printing – what can be achieved?
  • Late stage customisation – benefits to manufacturers
  • Anti-counterfeiting – sequential variable data and unique coding
  • Flexible solutions
  • 10:30 Morning Coffee

    11:00 SECURITY OF PACKAGING AND LABELLING IN THE SUPPLY-CHAIN

    Ralph Dillon

    Ralph Dillon, Director, ComplianceSurety Associates

  • Serious errors made in supply chain security previously
  • Why supply chain security is beneficial to both producer and patient?
  • Techniques for maintaining supply chain security
  • Labelling methods and techniques used to track products
  • Pilot trials for “track and trade” scheme
  • 11:40 PACKAGING SMALL ORDERS EFFICIENTLY - RESPONDING TO THE CHANGING MARKET - A CASE STUDY

    Jonathon Rucker

    Jonathon Rucker, Director of Manufacturing, Eli Lilly & Co

  • Current strategies to manage complexity
  • Late stage customization
  • Benefits of late stage customization
  • Working with the supply chain to implement
  • 12:20 Networking Lunch

    13:20 SECURITY AND SUSTAINABILITY IN PHARMACEUTICAL LABELLING

    Sven Tolsma

    Sven Tolsma, Marketing Manager, UPM Raflatac

  • Pressure sensitive materials and prescribing labelling material
  • Security labelling and long term availability of materials
  • Adhesive migration risk
  • New substates like Barex and Topas
  • 14:00 COUNTERFEIT PHARMACEUTICALS: THE “SILENT EPIDEMIC”

    Max Vetter

    Max Vetter, Manager, ICC Counterfeiting Intelligence Bureau

  • Counterfeit pharmaceuticals: A world overview of the current state of affairs
  • Counterfeiting and problems with wholesale & distribution
  • Exploring recent case studies
  • 14:40 Afternoon Tea

    15:10 THE USE OF PACKAGING TO IMPROVE THE HANDLING AND DISTRIBUTION OF PHARMACEUTICALS THROUGH THE WHOLESALE CHANNEL

    Tony Garlick

    Tony Garlick, Technical Director, BAPW

  • Information standards
  • Outer case labels
  • The use of machine readable codes
  • Pack design
  • Patient packs or bulk
  • 15:50 MANAGING ACCURACY & READABILITY OF MULTIPLE LANGUAGE LABELLING

    Martyn Kerluck

    Martyn Kerluck, Manager, prisymid

  • Managing space and readability issues
  • Ensuring consistency and accuracy
  • Ways to automate variable data to eliminate human error
  • 16:30 Chairman’s Closing Remarks and Close of Day Two

    +

    Workshops

    COUNTERFEIT PACKAGING - PROTECTING YOUR COMPANY
    Workshop

    COUNTERFEIT PACKAGING - PROTECTING YOUR COMPANY

    The Hatton, at etc. venues
    27th February 2008
    London, United Kingdom

    The Hatton, at etc. venues

    51/53 Hatton Garden
    London EC1N 8HN
    United Kingdom

    The Hatton, at etc. venues

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.